Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05259046
NA
The InterVitaminK Trial - Effects of Vitamin K Supplementation on Cardiovascular, Metabolic, and Bone Health
Sponsor: Bispebjerg Hospital
View on ClinicalTrials.gov
Summary
The purpose of this study is to examine the effect of menaquinone-7 (MK-7) supplementation on cardiovascular, metabolic, and bone health.
Official title: Novel Health Effects of Vitamin K: a Placebo-controlled Randomized Trial in the General Population (InterVitaminK)
Key Details
Gender
All
Age Range
50 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
450
Start Date
2022-06-21
Completion Date
2027-02-28
Last Updated
2026-02-17
Healthy Volunteers
Yes
Interventions
DIETARY_SUPPLEMENT
Menaquinone-7 (MK-7) tablet (333 µg)
One MK-7 tablet containing 333 µg MK-7 per day
DIETARY_SUPPLEMENT
Placebo tablet
One placebo tablet per day
Locations (1)
Center for Clinical Research and Prevention
Copenhagen, Glostrup, Denmark